MISSION Therapeutics
Develops drugs for cancer treatments
MISSION Therapeutics has raised €51M across 5 funding rounds from 7 investors, most recently a round in Oct 2025. Based in Cambridge, UK; founded 2015; active in Healthtech. Data as of 4 Nov 2026.
Total raised
€51M
€51,316,644
Funding rounds
5
Investors
7
distinct backers
Active since
2013-11
latest 2025-10
Funding by year
EUR raised per yearMISSION Therapeutics — funding by year — interactive chart.
Data table
| MISSION Therapeutics — funding by year | |
|---|---|
| 2013 | €24M |
| 2015 | €2.6M |
| 2020 | €13M |
| 2021 | €431k |
| 2025 | €11M |
Signals
High confidenceRaise-next likelihood46
base rate 30% for Other
- ▲ In typical raise window
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood25
base rate 11% (2+ rounds)
- ▲ €30M+ raised
- ▲ 5 rounds raised
- ▲ 11y since founding (typical exit age)
- ▲ Recently backed by strong-exit-track investors
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
5 rounds- 2025-10-17Other€11M
- 2021-10-14Grant€431k
- 2020-07-06Other€13M
- 2015-09-01Grant€2.6M
- 2013-11-01Series B€24M
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-10-17 | Other | €11M | IP Group,Pfizer Ventures,Roche Venture Fund,Rosetta Capital,Sofinnova Partners,SR One | View deal → |
| 2021-10-14 | Grant | €431k | Michael J Fox Foundation for Parkinson’s Research (MJFF) | View deal → |
| 2020-07-06 | Other | €13M | Pfizer Ventures | View deal → |
| 2015-09-01 | Grant | €2.6M | — | View deal → |
| 2013-11-01 | Series B | €24M | Roche Venture Fund,Sofinnova Partners | View deal → |
Investors
7Related news
Similar companies
same sector, similar size- SheMed€43MUK · Healthtech
- Bioniq€40MUK · Healthtech
- Sensible Biotechnologies€46MUK · Healthtech
- IMU Biosciences€59MUK · Healthtech
- Biofidelity€43MUK · Healthtech
- EnteroBiotix€42MUK · Healthtech
Global coverage: FundingData